Evidence map›Paper›PMID 41660336›Full record

ArticleSurgical neurology international2026

Sacral neuromodulation for the treatment of idiopathic non-obstructive urinary retention: A long-term follow-up case report.

Walter Fagundes, Sérgio Dantas, Martin Kotochinsky, Yasmin Picanco Silva, Paweł Łajczak, Ícaro Godeiro de Oliveira Maranhão, César Araújo Britto

Abstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Walter FagundesDepartment of Neurosurgery, Federal University of Espirito Santo, Vitoria, Brazil.
Sérgio DantasDepartment of Surgery, Division of Neurosurgery, University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Brazil.
Martin KotochinskyDepartment of Medicine, National University of Cuyo, Centro Universitario, Mendoza, Argentina.
Yasmin Picanco SilvaDepartment of Medicine, Healthcare Institution of South Iceland, Selfoss, Iceland.
Paweł ŁajczakDepartment of Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Ícaro Godeiro de Oliveira MaranhãoDepartment of Surgery, Division of Urology, University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Brazil.
César Araújo BrittoDepartment of Surgery, Division of Urology, University Hospital Onofre Lopes, Federal University of Rio Grande do Norte, Natal, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sacral neuromodulation (SNM) is a treatment used to manage urinary symptoms of both overactive bladder and non-obstructive urinary retention. The use of SNM in managing these symptoms has yielded positive results, contributing to a reduction in symptoms and an improvement in quality of life (QoL) for patients. This article aims to report on the electrical neurostimulation of sacral nerves to treat idiopathic non-obstructive urinary retention. Case Description: A 27-year-old female presented with chronic non-obstructive idiopathic urinary retention, using intermittent bladder catheterization, who did not respond to various treatments such as behavioral therapy, pelvic floor physiotherapy, and alpha-blockers. She underwent a sphincter injection of botulinum toxin type A. Due to the refractoriness of all previous treatments, electrical neurostimulation of the sacral nerves was proposed as an alternative. Two electrodes were implanted to stimulate the sacral nerves percutaneously in the foramina of S4 on both sides and connected to the neurostimulation system. Conclusion: After the procedure, the patient experienced a reduction in the average voiding residue (47% immediately postoperative and 29% after 1 year), a significant decrease in urinary tract infections and bladder catheterizations (50% reduction), along with improvements in urinary symptoms, abdominal discomfort, and a substantial enhancement in QoL.

Indexed as

Bladder overactivityElectrical nerve stimulationNeuromodulationSacral neuromodulationUrinary retention

Identifiers

PMID41660336
PMCPMC12875254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.